Integra NeuroSciences Launches New Non-Stick Bipolar Forceps
PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will market and sell the Integra BUZZ™ non-stick bipolar forceps. Bipolar forceps are an essential part of neurosurgery. The Integra BUZZ™ non-stick forceps, which are fully compatible with most standard electrosurgical generators, prevent tissue from sticking to forceps tips while still coagulating delicate structures in fine detail. The forceps come in a variety of length and tip sizes and can be used for most neurosurgical procedures.
"During delicate electrosurgery, unwanted tissue adhesion can slow down the surgeon and put patients at risk," said Deborah Leonetti, Integra's Senior Vice President of Marketing. "We developed the Integra BUZZ™ non-stick bipolar forceps to address this issue, providing surgeons with a safer way to stop the start-stick-stop that can occur in electrosurgery. The introduction of this product provides an example of Integra's ability to respond to the needs of surgeons."
The Integra BUZZ™ non-stick bipolar forceps will be sold by the Integra NeuroSciences™ sales organization. Integra NeuroSciences is a leading provider of implants, devices, instruments, and systems used in neurosurgery, neuromonitoring, neuro-trauma, and related critical care. Integra NeuroSciences' direct selling effort in the United States and Europe currently involves more than 130 professionals. In all other markets, Integra NeuroSciences products are sold through a network of distributors.
Integra LifeSciences Holdings Corporation is a diversified medical technology company. Integra develops, manufactures, and markets medical devices used in a variety of applications. The primary applications for our products are neuro-trauma and neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have research, manufacturing and distribution facilities located throughout the world. We have approximately 1,300 employees. Please visit our website at http://www.Integra-LS.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the use of the Integra BUZZ non-stick bipolar forceps. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of physicians to use the Integra BUZZ non-stick bipolar forceps may affect the prospects for their use in clinical procedures. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Factors That May Affect Our Future Performance" included in the Business section of Integra's Annual Report on Form 10-K for the year ended December 31, 2004 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
CONTACT:
Integra LifeSciences Holdings Corporation
John B. Henneman, III
Executive Vice President
Chief Administrative Officer
(609) 936-2481
jhenneman@Integra-LS.com
Maria Platsis
Senior Director of Corporate Development and
Investor Relations
(609) 936-2333
mplatsis@Integra-LS.com